Serum calcium levels are associated with cognitive function in hypoparathyroidism: a neuropsychological and biochemical study in an Italian cohort of patients with chronic post-surgical hypoparathyroidism.
Hypoparathyroidism
Neurocognitive evaluation
Parathyroid hormone
Post-surgical hypoparathyroidism
Journal
Journal of endocrinological investigation
ISSN: 1720-8386
Titre abrégé: J Endocrinol Invest
Pays: Italy
ID NLM: 7806594
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
09
02
2022
accepted:
06
05
2022
pubmed:
26
6
2022
medline:
14
9
2022
entrez:
25
6
2022
Statut:
ppublish
Résumé
Hypoparathyroidism (HypoPT) is a rare endocrine disease and conventional therapy is based on calcium and vitamin D analogues. Conventional therapy does not restore calcium homeostasis and patients complain with neuropsychological symptoms, which have been evaluated with nonspecific self-administered questionnaires. This study aims to evaluate cognitive functions of patients with chronic post-surgical (PS)-HypoPT compared to a control population, using a standardized neuropsychological approach and evaluating the relationship with serum calcium (Alb-Ca). Observational, monocentric study on 33 patients with PS-HypoPT and 24 controls, in whom biochemical testing and a standardized neuropsychological assessment by a trained psychologist were performed. In patients with PS-HypoPT, low Alb-Ca correlated with a worse performance on semantic memory abilities and executive function, as suggested by a significant inverse correlation between Alb-Ca and Trail Making Test A (TMT-A) scores (r = - 0.423; p = 0.014) and by a positive correlation with Semantic Fluency Test scores (SF)(r = 0.510; p = 0.002). PS-HypoPT patients with Alb-Ca ≤ 8.9 mg/dl had a significantly lower test performance compared with PS-HypoPT patients with Alb-Ca > 8.9 mg/dl, both at the TMT-A test (mean score: 34.53-18.55; p < 0.0001) and at SF test (mean score: 41.94-48.68; p = 0.01) and also a significantly lower test performance compared with control patients' group at TMT-A (mean score: 34.53-25.5; p = 0.0057). Patients with chronic PS-HypoPT in conventional therapy do not show a severe cognitive impairment; however, cognitive functions namely visuo-spatial attention, executive function and semantic memory appear to be modulated by Alb-Ca and impaired by its low levels.
Identifiants
pubmed: 35751804
doi: 10.1007/s40618-022-01822-6
pii: 10.1007/s40618-022-01822-6
pmc: PMC9463210
doi:
Substances chimiques
Calcium
SY7Q814VUP
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1909-1918Informations de copyright
© 2022. The Author(s).
Références
Front Genet. 2012 Oct 02;3:200
pubmed: 23060904
BMJ. 2008 Jun 7;336(7656):1298-302
pubmed: 18535072
J Bone Miner Res. 2013 Nov;28(11):2277-85
pubmed: 23661265
Eur J Endocrinol. 2002 Feb;146(2):215-22
pubmed: 11834431
Eur J Endocrinol. 2013 May 07;168(6):895-903
pubmed: 23482593
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
J Biol Chem. 1995 Jun 30;270(26):15455-8
pubmed: 7797535
J Clin Endocrinol Metab. 2018 Feb 1;103(2):722-731
pubmed: 29099947
J Clin Endocrinol Metab. 2019 Jul 1;104(7):2748-2756
pubmed: 30776291
Front Cell Neurosci. 2018 Nov 05;12:379
pubmed: 30455631
J Clin Endocrinol Metab. 2016 Jun;101(6):2300-12
pubmed: 26943721
Endocrinol Metab Clin North Am. 2018 Dec;47(4):855-864
pubmed: 30390818
N Engl J Med. 2008 Jul 24;359(4):391-403
pubmed: 18650515
Assessment. 2017 Mar;24(2):183-196
pubmed: 26318386
J Endocrinol Invest. 2021 May;44(5):905-919
pubmed: 32926396
J Bone Miner Res. 2008 Dec;23(12):2018-24
pubmed: 18684087
Brain Res. 1986 Oct 22;385(2):227-36
pubmed: 3096491
J Biol Phys. 2009 Oct;35(4):465-80
pubmed: 19669426
Curr Opin Rheumatol. 2019 Jul;31(4):381-387
pubmed: 31107289
Front Physiol. 2017 Oct 09;8:776
pubmed: 29062283
J Clin Exp Neuropsychol. 1997 Dec;19(6):795-809
pubmed: 9524875
Int J Mol Sci. 2020 Nov 06;21(21):
pubmed: 33171939
J Bone Miner Res. 2015 Sep;30(9):1738-44
pubmed: 25753591
Nat Neurosci. 1999 Nov;2(11):941-3
pubmed: 10526330
J Intellect Disabil Res. 2005 Oct;49(Pt 10):707-17
pubmed: 16162115
JBMR Plus. 2020 Jun 05;4(7):e10368
pubmed: 32666019
Int J Mol Sci. 2021 May 06;22(9):
pubmed: 34066371
Arch Clin Neuropsychol. 2004 Apr;19(3):375-90
pubmed: 15033223
Exp Clin Endocrinol Diabetes. 1997;105(6):336-40
pubmed: 9439929
J Clin Epidemiol. 2000 Jan;53(1):1-12
pubmed: 10693897
J Endocrinol Invest. 2021 Jul;44(7):1437-1446
pubmed: 33128157
J Clin Endocrinol Metab. 2016 Jun;101(6):2284-99
pubmed: 26943720
Cortex. 2014 May;54:150-64
pubmed: 24681692
J Bone Miner Res. 2014 Nov;29(11):2504-10
pubmed: 24806578
J Clin Endocrinol Metab. 2014 Oct;99(10):3694-9
pubmed: 24978675
Neurol Sci. 2008 Sep;29(4):209-17
pubmed: 18810594
Scand J Clin Lab Invest. 1988 Oct;48(6):489-94
pubmed: 3217751
Neuroscience. 2009 Aug 4;162(1):128-47
pubmed: 19401215
J Bone Miner Res. 2011 Oct;26(10):2317-37
pubmed: 21812031
Clin Endocrinol (Oxf). 2018 Jun;88(6):838-847
pubmed: 29520810
Endocrine. 2017 Jan;55(1):256-265
pubmed: 27033542
Neurol Sci. 2013 May;34(5):749-54
pubmed: 22689311
F1000Res. 2020 Jul 23;9:
pubmed: 32765831
Pract Neurol. 2018 Jun;18(3):227-237
pubmed: 29472384
J Clin Endocrinol Metab. 2016 Jun;101(6):2273-83
pubmed: 26943719
Front Endocrinol (Lausanne). 2012 Oct 08;3:121
pubmed: 23060860
J Comp Neurol. 2007 Jun 1;502(4):563-83
pubmed: 17394159
J Bone Miner Res. 2016 Jul;31(7):1440-8
pubmed: 26865527
Clin Endocrinol (Oxf). 2003 Feb;58(2):199-206
pubmed: 12580936
Annu Rev Neurosci. 2004;27:509-47
pubmed: 15217342
Arch Osteoporos. 2020 May 19;15(1):75
pubmed: 32430780
Front Pharmacol. 2012 Apr 13;3:61
pubmed: 22518105
Eur J Neurosci. 2010 Jul;32(2):218-23
pubmed: 20646046
Neuron. 2005 May 5;46(3):401-5
pubmed: 15882639
Arch Clin Neuropsychol. 2004 Mar;19(2):203-14
pubmed: 15010086
Genes Brain Behav. 2011 Feb;10(1):90-9
pubmed: 20796031
Neurol Sci. 2014 Sep;35(9):1405-11
pubmed: 24705901
J Endocrinol Invest. 2021 Feb;44(2):245-253
pubmed: 32661948
J Clin Endocrinol Metab. 2016 Aug;101(8):3045-53
pubmed: 27186861
J Endocrinol Invest. 2022 Mar;45(3):573-582
pubmed: 34637114
Clin Neuropsychol. 2007 Mar;21(2):209-31
pubmed: 17455014